Patients’ perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate – a qualitative interview study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patients’ perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate – a qualitative interview study

Published:2020-11-05 Issue:4 Volume:75 Page:257-265
ISSN:0803-9488
Container-title:Nordic Journal of Psychiatry
language:en
Short-container-title:Nordic Journal of Psychiatry

Author:

Rise Marit B.¹,Stølan Liv Os²,Erdner Anette³,Hedberg Berith⁴,Stahl Katja⁵,Riise Jesper⁶,Jedenius Erik⁷,Møllerhøj Jette²

Affiliation:

1. Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway

2. Competence Centre for Forensic Psychiatry, Mental Health Centre Sct. Hans, Roskilde, Denmark

3. Department of Health Care Sciences, Ersta Sköndal Bräcke University, Stockholm, Sweden

4. IMPROVE Research Group, School of Health and Welfare, Jönköping University, Sweden

5. Medical Department, Janssen Cilag AS Norway, Oslo, Norway

6. Medical Department, Janssen Cilag AS Denmark, Birkerød, Denmark

7. Medical Department, Janssen Cilag AS Sweden, Stockholm, Sweden

Funder

Janssen Cilag

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08039488.2020.1841289

Reference39 articles.

1. Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia

2. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

3. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing

4. Psychiatrists’ use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years

5. The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy;Current Medical Research and Opinion;2023-12

2. One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives;Patient Preference and Adherence;2022-03

3. Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study;Expert Opinion on Pharmacotherapy;2022-01-05

4. Approved and marketed nanoparticles for disease targeting and applications in COVID-19;Nanotechnology Reviews;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3